Table 3.
Crude and mutually adjusted heart age deviation (difference from comparator group*) according to patient characteristics for non-smokers and smokers
| Variable | All individuals (N=749) |
|||
|---|---|---|---|---|
| Non smoker deviation (years) (95% CI) |
Smoker deviation (years) (95% CI) |
|||
| Crude | Adjusted | Crude | Adjusted | |
| Female vs male | −1.65 (−3.25 to −0.05) | −0.96 (−2.52 to 0.59) | −2.32 (−4.38 to −0.25) | −0.72 (−2.62 to 1.18) |
| Age category | – | – | – | – |
| 18–39* | – | – | – | – |
| 40–49 | 3.02 (1.35 to 4.69) | 3.38 (1.66 to 5.10) | 6.48 (4.44 to 8.52) | 6.75 (4.65 to 8.86) |
| 50–59 | 6.27 (4.11 to 8.43) | 6.39 (4.17 to 8.61) | 12.64 (10.00 to 15.27) | 12.64 (9.94 to 15.35) |
| 60+ | 8.26 (5.36 to 11.16) | 8.87 (5.90 to 11.84) | 16.67 (13.13 to 20.20) | 17.21 (13.59 to 20.83) |
| CD4 count category (cells/mm3) | – | – | – | – |
| <500* | – | – | – | – |
| 500–750 | 1.91 (0.23 to 3.60) | 2.39 (0.74 to 4.03) | 2.50 (0.34 to 4.66) | 3.01 (1.00 to 5.02) |
| ≥750 | 4.23 (2.23 to 6.23) | 4.28 (2.28 to 6.27) | 6.12 (3.55 to 8.68) | 5.44 (3.01 to 7.87) |
| Viral load category | – | – | – | – |
| Treated with suppressed vl* | – | – | – | – |
| Treated with unsuppressed vl | 1.07 (−1.44 to 3.59) | 2.84 (0.40 to 5.29) | −0.19 (−3.42 to 3.04) | 2.90 (−0.08 to 5.89) |
| Untreated | −1.39 (−3.36 to 0.58) | 0.27 (−1.74 to 2.27) | −3.61 (−6.15 to −1.07) | −0.28 (−2.73 to 2.17) |
| ART start date pre 01/01/2003 | 0.18 (−1.62 to 1.99) | −2.28 (−4.14 to −0.42) | 1.98 (−0.35 to 4.30) | −2.43 (−4.70 to −0.17) |
| Constant | – | −1.26 (−3.00 to 0.49) | – | 6.70 (4.57 to 8.82) |
ART, antiretroviral therapy.